Sumitomo Mitsui Trust Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Buy |
4,481
+2,340
| +109% | +$355K | ﹤0.01% | 891 |
|
|
2025
Q1 | $322K | Sell |
2,141
-122,956
| -98% | -$18.5M | ﹤0.01% | 978 |
|
|
2024
Q4 | $23.1M | Buy |
125,097
+13,102
| +12% | +$2.42M | 0.02% | 621 |
|
|
2024
Q3 | $22.1M | Buy |
111,995
+3,714
| +3% | +$732K | 0.02% | 627 |
|
|
2024
Q2 | $22.4M | Sell |
108,281
-9,817
| -8% | -$2.03M | 0.02% | 615 |
|
|
2024
Q1 | $32M | Sell |
118,098
-1,940
| -2% | -$526K | 0.02% | 612 |
|
|
2023
Q4 | $28.4M | Sell |
120,038
-2,240
| -2% | -$530K | 0.02% | 636 |
|
|
2023
Q3 | $24M | Sell |
122,278
-115
| -0.1% | -$22.5K | 0.02% | 658 |
|
|
2023
Q2 | $25.7M | Sell |
122,393
-18,726
| -13% | -$3.94M | 0.02% | 654 |
|
|
2023
Q1 | $28.5M | Sell |
141,119
-1,066
| -0.7% | -$215K | 0.02% | 646 |
|
|
2022
Q4 | $31M | Sell |
142,185
-615
| -0.4% | -$134K | 0.02% | 629 |
|
|
2022
Q3 | $28.1M | Sell |
142,800
-1,472
| -1% | -$290K | 0.02% | 642 |
|
|
2022
Q2 | $30.9M | Buy |
144,272
+7,848
| +6% | +$1.68M | 0.02% | 643 |
|
|
2022
Q1 | $38.7M | Sell |
136,424
-895
| -0.7% | -$254K | 0.03% | 606 |
|
|
2021
Q4 | $51.7M | Sell |
137,319
-4,714
| -3% | -$1.78M | 0.03% | 528 |
|
|
2021
Q3 | $58.6M | Sell |
142,033
-7,240
| -5% | -$2.99M | 0.04% | 496 |
|
|
2021
Q2 | $55.2M | Buy |
+149,273
| New | +$55.2M | 0.03% | 526 |
|
|
2021
Q1 | – | Sell |
-14,682
| Closed | -$3.67M | – | 1157 |
|
|
2020
Q4 | $3.67M | Buy |
+14,682
| New | +$3.67M | ﹤0.01% | 856 |
|